Yunfei Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yunfei Huang has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Jun Yang
Albany Medical College
5 shared publicationsXinjun Zhu
Albany Medical College
4 shared publicationsDavid Conti
Albany Medical College
2 shared publicationsGabrielle Ritaccio
Albany Medical College
2 shared publicationsJ. McMahon
2 shared publicationsJohn McMahon
Center for Neuropharmacology and Neuroscience, Albany Medical College, Albany, New York 12208, USA
2 shared publications
Latest Publications
- 1 January 2015
- Published by Elsevier in Neurobiology of Disease
- Vol. 73, 296-306
Seizure-dependent mTOR activation in 5-HT neurons promotes autism-like behaviors in mice
- 1 January 2015
- Published by Elsevier in Neurobiology of Disease
- Vol. 73, 296-306
Seizure-dependent mTOR activation in 5-HT neurons promotes autism-like behaviors in mice
- Open Access
- 7 November 2012
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 32 (45) , 15704-15714
Impaired Autophagy in Neurons after Disinhibition of Mammalian Target of Rapamycin and Its Contribution to Epileptogenesis
Certain mutations within the mammalian target of rapamycin (mTOR) pathway, most notably those affecting the tuberous sclerosis complex (TSC), lead to aberrant activation of mTOR and result in a high incidence of epilepsy in humans and animal models. Although hyperactivation of mTOR has been strongly linked to the development of epilepsy and, conversely, inhibition of mTOR by rapamycin treatment is protective against seizures in several models, the downstream epileptic mechanisms have remained elusive. Autophagy, a catabolic process that plays a vital role in cellular homeostasis by mediating the turnover of cytoplasmic constituents, is negatively regulated by mTOR. Here we demonstrate that autophagy is suppressed in brain tissues of forebrain-specific conditional TSC1 and phosphatase and tensin homlog knock-out mice, both of which display aberrant mTOR activation and seizures. In addition, we also discovered that autophagy is suppressed in the brains of human TSC patients. Moreover, conditional deletion ofAtg7, an essential regulator of autophagy, in mouse forebrain neurons is sufficient to promote development of spontaneous seizures. Thus, our study suggests that impaired autophagy contributes to epileptogenesis, which may be of interest as a potential therapeutic target for epilepsy treatment and/or prevention.
- 7 November 2012
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 32 (45) , 15704-15714
Open AccessImpaired Autophagy in Neurons after Disinhibition of Mammalian Target of Rapamycin and Its Contribution to Epileptogenesis
Certain mutations within the mammalian target of rapamycin (mTOR) pathway, most notably those affecting the tuberous sclerosis complex (TSC), lead to aberrant activation of mTOR and result in a high incidence of epilepsy in humans and animal models. Although hyperactivation of mTOR has been strongly linked to the development of epilepsy and, conversely, inhibition of mTOR by rapamycin treatment is protective against seizures in several models, the downstream epileptic mechanisms have remained elusive. Autophagy, a catabolic process that plays a vital role in cellular homeostasis by mediating the turnover of cytoplasmic constituents, is negatively regulated by mTOR. Here we demonstrate that autophagy is suppressed in brain tissues of forebrain-specific conditional TSC1 and phosphatase and tensin homlog knock-out mice, both of which display aberrant mTOR activation and seizures. In addition, we also discovered that autophagy is suppressed in the brains of human TSC patients. Moreover, conditional deletion ofAtg7, an essential regulator of autophagy, in mouse forebrain neurons is sufficient to promote development of spontaneous seizures. Thus, our study suggests that impaired autophagy contributes to epileptogenesis, which may be of interest as a potential therapeutic target for epilepsy treatment and/or prevention.
- 1 September 2012
- Published by Elsevier in Neuroscience
- Vol. 219, 33-47
Rapamycin down-regulates KCC2 expression and increases seizure susceptibility to convulsants in immature rats
- 1 September 2012
- Published by Elsevier in Neuroscience
- Vol. 219, 33-47
Rapamycin down-regulates KCC2 expression and increases seizure susceptibility to convulsants in immature rats
- Open Access
- 1 July 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (29) , 24795-24806
Leucine Stimulates Insulin Secretion via Down-regulation of Surface Expression of Adrenergic α2A Receptor through the mTOR (Mammalian Target of Rapamycin) Pathway
- 1 July 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (29) , 24795-24806
Open AccessLeucine Stimulates Insulin Secretion via Down-regulation of Surface Expression of Adrenergic α2A Receptor through the mTOR (Mammalian Target of Rapamycin) Pathway
- 1 July 2012
- Published by Elsevier in Neuroscience
- Vol. 215, 90-97
Rapamycin attenuates aggressive behavior in a rat model of pilocarpine-induced epilepsy
- 1 July 2012
- Published by Elsevier in Neuroscience
- Vol. 215, 90-97
Rapamycin attenuates aggressive behavior in a rat model of pilocarpine-induced epilepsy
- 1 January 2011
- Published by Elsevier in Neuroscience
- Vol. 172, 104-109
Inhibition of the mammalian target of rapamycin pathway by rapamycin blocks cocaine-induced locomotor sensitization
- 1 January 2011
- Published by Elsevier in Neuroscience
- Vol. 172, 104-109
Inhibition of the mammalian target of rapamycin pathway by rapamycin blocks cocaine-induced locomotor sensitization
- 1 October 2010
- Published by Elsevier in Neurobiology of Disease
- Vol. 40 (1) , 193-199
Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy
- 1 October 2010
- Published by Elsevier in Neurobiology of Disease
- Vol. 40 (1) , 193-199
Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy